Hospital de Clínicas "Jose de San Martin" Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2017
NCT03331770
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital de Clínicas "Jose de San Martin" | Hospital de Clinicas José de San Martín | SILVATEAM

Active Ingredients

Drugs in Phase 4 Trials (1)

latanoprost (xalatan) (1 trial)

Drugs in Other Trials (1)

polyphenols (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2